In order to meet the demand for cell therapy products and the growing need for effective therapeutic interventions, developers are actively outsourcing certain manufacturing operations, in addition to expanding their in-house capabilities
Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Therapy Manufacturing Market (4th Edition), 2021-2030.”
The report features an extensive study of the current market landscape and future opportunities associated with cell therapy manufacturing, along with information on both contract manufacturers, as well as developers having in-house production capabilities, offering in-depth analyses of the various business entities engaged in this domain, across key global regions. Amongst other elements, the report includes:
A detailed review of the overall landscape of players engaged in the manufacturing of cell-based therapies, along with information on type of cell manufactured, source of cell, scale of operation, purpose of production, manufacturing capabilities / services offered, as well as location of headquarters and their respective manufacturing facilities.An analysis of the various expansion initiatives undertaken by service providers engaged in this domain in order to augment their respective cell therapy manufacturingAn analysis of the recent partnerships focused on the manufacturing of cell-based therapies, which have been established during the period 2016-2021.A review of the various cell therapy manufacturing initiatives undertaken by big pharma players engaged in this domain.Informed estimates of the annual commercial and clinical demand for cell therapies (in terms of number of patients).An estimate of the overall, installed capacity for the manufacturing of cell-based therapies.An in-depth analysis of cell therapy manufacturers using three versatile representations.A detailed analysis of various factors that are likely to influence the price of cell-based therapies.An elaborate discussion on the role of automation technologies in improving the current manufacturing methods.A qualitative analysis, highlighting the various factors that need to be taken into consideration by cell therapy developers, while deciding whether to manufacture their respective products in-house or engage the services of a CMO.A discussion on cell therapy manufacturing regulations across various geographies.Elaborate profiles of key players (industry and non-industry) that offer contract manufacturing services for cell-based therapies.A discussion on affiliated trends, key drivers and challenges, which are likely to impact the industry's evolution, under an elaborate SWOT framework.Insights generated in a market-wide survey, featuring inputs solicited from experts who are directly / indirectly involved in the development and / or manufacturing of cell-based therapies.A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)Type of Cell TherapyT cell therapiesDendritic and tumor cell therapiesNK cell therapiesStem cell therapiesOther ATMPsSource of CellAutologousAllogeneicScale of OperationClinicalCommercialPurpose of ManufacturingIn-house ManufacturingContract ManufacturingGeographical RegionsNorth AmericaEuropeAsia PacificRest of the World
To request a sample copy / brochure of this report, please visit this
https://www.rootsanalysis.com/reports/285/request-sample.html
Key companies covered in the report
BioNTech Innovative Manufacturing ServicesCell and Gene Therapy CatapultCell TherapiesCenter for Cell and Gene Therapy, Baylor College of MedicineCenter for Cell Manufacturing Ireland, National University of IrelandClinical Cell and Vaccine Production Facility, University of PennsylvaniaCognate BioServicesFUJIFILM Cellular DynamicsGuy's and St. Thomas GMP Facility, Guy's HospitalKBI BiopharmaLaboratory for Cell and Gene Medicine, Stanford UniversityLonzaMEDINETMinaris Regenerative MedicineMolecular and Cellular Therapeutics, University of MinnesotaNewcastle Cellular Therapies Facility, Newcastle UniversityNikon CeLL innovationRayne Cell Therapy Suite, King's College LondonRoslin Cell TherapiesScottish National Blood Transfusion Service, Scottish Centre of Regenerative MedicineSydney Cell and Gene TherapyWaisman BiomanufacturingWuXi AppTec
For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html
Other Recent Offerings
Biologics Fill / Finish Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030Vaccine Contract Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, 2021-2030TIL-based Therapies Market: Industry Trends and Global Forecasts, 2021-2030TCR-based Therapies Market: Industry Trends and Global Forecasts, 2021-2030Global T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition): Industry Trends and Global Forecasts, 2021-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Medium - https://medium.com/@RootsAnalysis
Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
Quora - https://rootsanalysisinsights.quora.com/
0